172 related articles for article (PubMed ID: 33960154)
1. [Current approach to diagnosis of chronic prostatitis].
Kulchavenya EV; Brijatuk EV; Kholtobin DP; A CG
Urologiia; 2021 May; (2):32-39. PubMed ID: 33960154
[TBL] [Abstract][Full Text] [Related]
2. [New opportunities of using gialuronidase in chronic prostatitis].
Kulchavenya EV; Shevchenko SY; Cherednichenko AG; Breusov AA; Vinitskiy AA
Urologiia; 2020 Jun; (3):56-62. PubMed ID: 32597587
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy for chronic bacterial prostatitis.
Perletti G; Marras E; Wagenlehner FM; Magri V
Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
5. [The efficiency of various cytokine therapy regimens in the complex treatment of men with chronic abacterial prostatitis].
Gyaurgiev TA; Kuzmenko AV; Kuzmenko VV
Urologiia; 2023 Mar; (1):12-19. PubMed ID: 37401678
[TBL] [Abstract][Full Text] [Related]
6. Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis.
Stamatiou K; Magri V; Perletti G; Trinchieri A; Lacroix R; Rekleiti N; Moschouris H
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266275
[TBL] [Abstract][Full Text] [Related]
7. [Spermoprotective properties of Prostatex in patients with chronic abacterial prostatitis].
Neymark AI; Davydov AV; Neymark BA; Nozdrachev NA; Melnik MA; Kablova IV; Borisenko DV; Tupyakova SG; Kovaleva YS
Urologiia; 2023 Mar; (1):54-59. PubMed ID: 37401684
[TBL] [Abstract][Full Text] [Related]
8. Common Questions About Chronic Prostatitis.
Holt JD; Garrett WA; McCurry TK; Teichman JM
Am Fam Physician; 2016 Feb; 93(4):290-6. PubMed ID: 26926816
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of chronic prostatitis by primary care providers.
Lovejoy B
J Am Acad Nurse Pract; 2001 Jul; 13(7):317-21; quiz 322-4. PubMed ID: 11930605
[TBL] [Abstract][Full Text] [Related]
10. [Rationale of use and effectiveness of Longidaza in patients with chronic prostatitis].
Kulchavenya EV; Shvetsova OP; Breusov AA
Urologiia; 2018 Oct; (4):64-71. PubMed ID: 30761792
[TBL] [Abstract][Full Text] [Related]
11. How I manage bacterial prostatitis.
Lam JC; Lang R; Stokes W
Clin Microbiol Infect; 2023 Jan; 29(1):32-37. PubMed ID: 35709903
[TBL] [Abstract][Full Text] [Related]
12. The value of endotoxin concentrations in expressed prostatic secretions for the diagnosis and classification of chronic prostatitis.
Li LJ; Shen ZJ; Lu YL; Fu SZ
BJU Int; 2001 Oct; 88(6):536-9. PubMed ID: 11678746
[TBL] [Abstract][Full Text] [Related]
13. Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse.
Stamatiou K; Pierris N
Investig Clin Urol; 2017 Jul; 58(4):271-280. PubMed ID: 28681038
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic bacterial prostatitis.
Hanus PM; Danziger LH
Clin Pharm; 1984; 3(1):49-55. PubMed ID: 6365416
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline.
Rees J; Abrahams M; Doble A; Cooper A;
BJU Int; 2015 Oct; 116(4):509-25. PubMed ID: 25711488
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
[TBL] [Abstract][Full Text] [Related]
17. [Acute prostatitis associated with noncancerous prostate at the Lubumbashi University Clinics: epidemioclinical and therapeutic features].
Banza MI; Kasanga TK; Mukakala AK; N'dwala YTB; Ngoie CN; Cabala VPK; Shutsha NT; Lire LI; Unen EW; Kapessa ND
Pan Afr Med J; 2020; 37():290. PubMed ID: 33654514
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the effectiveness of various regimens of the immunomodulatory drug Superlimf in the prevention of relapses of chronic abacterial prostatitis].
Gyaurgiev T A; Kuzmenko A V; KuzmenkoV V; Zolotukhin O V; Madykin Yu Y; Avdeev A I
Urologiia; 2024 Mar; (1):71-79. PubMed ID: 38650409
[TBL] [Abstract][Full Text] [Related]
19. [Extended culture study as a keypoint to rethinking antibiotic therapy for chronic bacterial prostatitis].
Kogan MI; Ibishev KS; Naboka YL; Gudima IA; Ismailov RS
Urologiia; 2023 Mar; (1):5-11. PubMed ID: 37401677
[TBL] [Abstract][Full Text] [Related]
20. [Correction of complement system failure in patients with chronic prostatitis].
Teodorovich OV; Shatokhin MN; Mykolaenko TV; Konoplia AI; Krasnov AV; Mavrin MIu; Meshanin NV
Urologiia; 2011; (4):29-32. PubMed ID: 22066238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
